Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study

British Medical Journal

Volumn 332, Issue 7535, 2006, Pages 202-206

  Biondi Zoccai, Giuseppe G L ^a,b   Lotrionte, Marzia ^c   Abbate, Antonio ^d   Testa, Luca ^c   Remigi, Enrico ^e   Burzotta, Francesco ^c   Valgimigli, Marco ^f   Romagnoli, Enrico ^g   Crea, Filippo ^c   Agostoni, Pierfrancesco ^h  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g CATHOLIC UNIVERSITY   (Italy)

^h MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM;

CLINICAL TRIAL; COCHRANE LIBRARY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG USE; EMBASE; FUNDING; HUMAN; KIDNEY DISEASE; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OXMAN AND GUYATT QUALITY INDEX; PREDICTION; PRIORITY JOURNAL; PROFIT; PUBLICATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; QUOROM SCORE; REVIEW; SCISEARCH; SCORING SYSTEM; SYSTEMATIC REVIEW; VALIDITY;

ACETYLCYSTEINE; CONTRAST MEDIA; GUIDELINE ADHERENCE; HUMANS; JOURNALISM, MEDICAL; KIDNEY DISEASES; META-ANALYSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS; RESEARCH SUPPORT; REVIEW LITERATURE;

EID: 31644436390     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38693.516782.7C     Document Type: Review

References (18)

1. Chalmers TC, Berrier J, Sacks HS, Levin H, Reitman D, Nagalingam R. Meta-analysis of clinical trials as scientific discipline. II: replicate variability and comparison of studies that agree and disagree. Stat Med 1987;6:733-44.
2. Assendelft WJJ, Koes BW, Knipschild PG, Bouter LM. The relationship between methodological quality and conclusions in reviews of spinal manipulation. JAMA 1995;274;1942-8.
3. Moher D, Olkin I. Meta-analysis of randomized controlled trials: a concern for standards. JAMA 1995;274:1962-4.
4. Cook DJ, Reeve BK, Guyatt GH, Griffith LE, Heyland DK, Tryba M. Stress ulcer prophylaxis in the critically ill: resolving discordant meta-analyses. JAMA 1996;275:308-14.
5. Hopayian K. The need for caution in interpreting high quality systematic reviews. BMJ 2001;323:681-4.
6. Jadad AR, Cook DJ, Browman GP. A guide to interpreting discordant systematic reviews. CMAJ 1997;156:1411-6.
7. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta-analysis on treatment of asthma: critical review. BMJ 2000;320:537-40.
8. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DE, for the QUOROM Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-1900.
9. Shojania KG, Bero LA. Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy. Effect Clin Pract 2001;4:157-62.
10. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group. 2001.
11. Lau J, Ioannidis JPA, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
12. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991;44:1271-8.
13. McGinn T, Guyatt G, Cook R, Meade M. Diagnosis: measuring agreement beyond chance. In: Guyatt G, Rennie D, eds. Users' guide to the medical literature. A manual for evidence-based clinical practice. Chicago, IL: AMA Press, 2002:461-70.
14. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004;364:583-91.
15. Hill RA, Dundar Y, Bakhai A, Dickson R, Walley T. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 2004;25:902-19.
16. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167.
17. In: Clarke M, Oxman A, eds. Cochrane reviewers' handbook 4.2.0. www.cochrane.org/resources/handbook/handbook.pdf (accessed 30 June, 2005).
18. Biondi-Zoccai GGL, Agostoni P, Abbate A. Parallel hierarchy of scientific studies in cardiovascular medicine. Ital Heart J 2003;4:819-20.